Nemo Healthcare

To further strengthen our growing company and the development of our technology and services, we are looking for a talented and passionate new team member.

Nemo Healthcare focusses on the improvement of fetal monitoring, based on electrophysiological signals, non-invasively recorded on the maternal abdomen.

Nemo Healthcare delivers a non-invasive solution for fetal monitoring. Our products bring comfort for both mother and child, and the best possible information at the right time for clinicians, aiming for safe births and healthy children.

Safe and Accurate Fetal Monitoring - DLV-719500

In 2015, Nemo applied for an EU Horizon 2020 SME (Small and Medium Sized Enterprises) Phase 2 grant, after successfully completing an SME Phase 1 grant earlier that year. The Phase 2 grant was awarded in 2016 for the development of novel technologies to improve fetal monitoring.

With this grant, we have developed the Nemo Fetal Monitoring Solution (NFMS), based on the technology of electrophysiological monitoring. Our solution enables medical professionals to obtain reliable information to better assess fetal wellbeing along pregnancy, in labor and delivery. 

 

Nemo Healthcare improves the way fetal assessment takes place, providing high-quality information to care givers in a safe and patient-friendly way.
 

We believe that reliable and early information leads to better decision-making,
resulting in improved health outcome that may lead to reduced healthcare costs.